Advertisement

Annals of Hematology

, Volume 96, Issue 7, pp 1221–1222 | Cite as

Successful treatment with bendamustine and rituximab for paraneoplastic pemphigus

  • Taku KikuchiEmail author
  • Takehiko Mori
  • Takayuki Shimizu
  • Yuya Koda
  • Ryohei Abe
  • Yuichi Kurihara
  • Takeru Funakoshi
  • Jun Yamagami
  • Hidekazu Sato
  • Kazuyuki Tsunoda
  • Masayuki Amagai
  • Shinichiro Okamoto
Letter to the Editor

Keywords

Prednisolone Follicular Lymphoma Malignant Lymphoma Bendamustine Basal Cell Layer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Compliance with ethical standards

Conflict of interest

SO received research funding and honoraria from Eisai Co. Ltd. and Chugai Pharmaceutical Co. Ltd. TM received honoraria from Eisai Co. Ltd. and Chugai Pharmaceutical Co. Ltd. TF received research funding and honoraria from Eisai Co. Ltd. and Chugai Pharmaceutical Co. Ltd.

References

  1. 1.
    Anhalt GJ, Kim SC, Stanley JR, Korman NJ, Jabs DA, Kory M, Izumi H, Ratrie H 3rd, Mutasim D, Ariss-Abdo L, Larib RS (1990) Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 323:1729–1735CrossRefPubMedGoogle Scholar
  2. 2.
    Yong AA, Tey HL (2013) Paraneoplastic pemphigus. Australas J Dermatol 54:241–250CrossRefPubMedGoogle Scholar
  3. 3.
    Nishibori Y, Hashimoto T, Ishiko A, Shimizu H, Korman NJ, Nishikawa T (1995) Paraneoplastic pemphigus: the first case report from Japan. Dermatology 191:39–42CrossRefPubMedGoogle Scholar
  4. 4.
    Stark GL, Goff DK, Spickett GP, Wojnarowska F, Langtry JA (2003) Paraneoplastic pemphigus occurring after radiotherapy for relapsed non-Hodgkin’s lymphoma in a patient with common variable immunodeficiency. Hematol J 4:154–158CrossRefPubMedGoogle Scholar
  5. 5.
    Plumb R, Doolittle GC (1996) Paraneoplastic pemphigus in a patient with non-Hodgkin’s lymphoma. Am J Hematol 52:58–59CrossRefPubMedGoogle Scholar
  6. 6.
    Anan T, Shimizu F, Hatano Y, Okamoto O, Katagiri K, Fujiwara S (2011) Paraneoplastic pemphigus associated with corneal perforation and cutaneous alternariosis: a case report and review of cases treated with rituximab. J Dermatol 38:1084–1089CrossRefPubMedGoogle Scholar
  7. 7.
    Rummel M, Kaiser U, Balser C, Stauch M, Brugger W, Welslau M, Niederle N, Losem C, Boeck HP, Weidmann E, von Gruenhagen U, Mueller L, Sandherr M, Hahn L, Vereshchagina J, Kauff F, Blau W, Hinke A, Barth J; Study Group Indolent Lymphomas. Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial. Lancet Oncol. 2016;17:57–66.Google Scholar
  8. 8.
    Rummel MJ, Niederle N, Maschmeyer G, Banat GA, von Grünhagen U, Losem C, Kofahl-Krause D, Heil G, Welslau M, Balser C, Kaiser U, Weidmann E, Dürk H, Ballo H, Stauch M, Roller F, Barth J, Hoelzer D, Hinke A, Brugger W; Study group indolent Lymphomas (StiL). Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial. Lancet 2013;381:1203–1210.Google Scholar
  9. 9.
    Higo T, Miyagaki T, Nakamura F, Shinohara A, Asano H, Abe H, Senda N, Yoshizaki A, Fukayama M, Kurokawa M (2015) Paraneoplastic pemphigus occurring after bendamustine and rituximab therapy for relapsed follicular lymphoma. Ann Hematol 94:683–685CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  • Taku Kikuchi
    • 1
    Email author
  • Takehiko Mori
    • 1
  • Takayuki Shimizu
    • 1
  • Yuya Koda
    • 1
  • Ryohei Abe
    • 1
  • Yuichi Kurihara
    • 2
  • Takeru Funakoshi
    • 2
  • Jun Yamagami
    • 2
  • Hidekazu Sato
    • 3
  • Kazuyuki Tsunoda
    • 3
  • Masayuki Amagai
    • 2
  • Shinichiro Okamoto
    • 1
  1. 1.Division of Hematology, Department of MedicineKeio University School of MedicineTokyoJapan
  2. 2.Department of DermatologyKeio University School of MedicineTokyoJapan
  3. 3.Department of Dentistry and Oral SurgeryKeio University School of MedicineTokyoJapan

Personalised recommendations